Prof. De Braud Filippo

Filippo de Braud, MD, is currently Full Professor of Medical Oncology, Director of Medical Oncology and Hematology Department, Director of Medical Oncology Division of the Istituto Nazionale dei Tumori Milan, where his principal area of expertise are “new drugs development”, clinical and translational research in Medical Oncology.

In 1984 Prof. de Braud received his medical degree in medicine from the University of Milan and continued his training in oncology at various institutions, including Istituto Nazionale Tumori Milano (Division directed by DR Gianni Bonadonna), the Royal Free Hospital School of Medicine, London, UK, the Wayne State University, Detroit, MI, USA., and the Institute Gustave Roussy, Paris, FR. 

He has held clinical posts at the European Institute of Oncology, where he was appointed Deputy Director of the Medical Oncology Division in 1994, later becoming Director of Clinical Pharmacology and New Drugs Development Unit.

Since August 2011 he was then appointed as Chief of Division of Medical Oncology 1 and as chief of Medical Oncology and Hematology Department at Fondazione IRCCS Istituto Nazionale Tumori, Milano , IT.

He leads researchers in new drugs development (Phase I and early Phase II studies) and teaches Medical Oncology as full professor at Università degli Studi di Milano.

Since 2000, he has been appointed Scientific Advisor and Member of Committee at Italian Medicine Agency AIFA, Ministry of Health, and several Pharmaceutical Companies.

Since February 2023 he is appointed as member of Board of Director for Cancer Core Europe.
He is author or coauthor of over 700 publications in medical oncology (H-index: 80)